BRAF mutations in patients with non-small cell lung cancer: a systematic review and meta-analysis.
about
The minority report: targeting the rare oncogenes in NSCLCA consensus statement on the gender perspective in lung cancer.A meta-analysis of the association between BRAF mutation and nonsmall cell lung cancerGene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in TaiwanPrevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung AdenocarcinomaDasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutationsReal-time tests of multiple genome alterations take the first steps into the clinic: a learning example.Epiregulin as a therapeutic target in non-small-cell lung cancerClinicopathologic characteristics and outcomes of Chinese patients with non-small-cell lung cancer and BRAF mutation.Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues.miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cellsMolecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC).Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?Pharmacogenomics in the treatment of lung cancer: an update.Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma.[Progress in the Treatment of Non-small Cell Lung Cancer with BRAF Inhibitors].BRAF V600Q-mutated lung adenocarcinoma with duodenal metastasis and extreme leukocytosis.Gastric Metastases from Lung Adenocarcinoma Causing Gastrointestinal Bleeding.Detection of EGFR and BRAF mutations by competitive allele-specific TaqMan polymerase chain reaction in lung adenocarcinoma.Prevalence and Clinicopathological Characteristics of BRAF Mutations in Chinese Patients with Lung Adenocarcinoma.Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience.Efficacy of vemurafenib in a heavy smoker with BRAF-mutated lung adenocarcinoma: A case report and literature reviewFrequency of actionable alterations in epidermal growth factor receptor wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR)
P2860
Q26851636-862818A7-1A6F-4896-94A9-C82118F8FB50Q30240700-82580EE7-9B33-4660-ADF5-C3CC9AB2B45FQ33621342-0340C401-DCE5-4320-ACC1-0AAA5117D1DFQ35016510-B2D0055D-4511-4A36-80E5-67FDEEC98F06Q35196603-4AD94DB4-E01E-4099-8609-D644DEC88845Q35671830-05B0A3D6-5968-4C9B-BE93-B9794BCA7EA6Q36729471-35944E80-F6B3-4524-8812-DC3B7B5FC05BQ37235168-C0524662-88A1-4B58-A05B-910BFDDDA264Q37566850-1C8DBA75-00A8-46C8-800F-9ABE87E31CE9Q37693426-126830C2-D4E5-4420-8876-A70BE9445E58Q38257364-2741B555-1B13-48D8-AD39-795ED86BA6F9Q38301306-C89D60AF-3E4D-4CFE-A35F-755E179C5748Q38358410-431B76E1-F004-4426-8E0C-440661DDBD59Q38584814-80F7BE80-C013-4C8D-B5DB-D170DAA580F1Q38596926-8C30209B-6CD4-49F2-81C6-E7881667A1D5Q38732942-9E561396-BB11-4ABC-A25E-99AA57DA5378Q40530427-8AC74FC8-25B5-4D12-8077-766FC13C6F90Q41374639-317230D4-2EE4-4673-B623-7445BFB3217EQ42317787-FF84FFF1-75A1-4948-A92E-FE000D5B7B3DQ50192132-D6AFF502-0480-4676-BA80-A8DBD4B885B4Q53412605-5F77640A-362D-4120-9A59-2FE436827BF9Q54981550-510914EC-EFE2-4803-BDA5-16D5C26EC148Q58798453-B56CA6FD-08FC-4FC6-935D-749231E400DFQ58804420-C643FE8B-38FD-40F2-AC5C-40A81153660D
P2860
BRAF mutations in patients with non-small cell lung cancer: a systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
BRAF mutations in patients wit ...... atic review and meta-analysis.
@ast
BRAF mutations in patients wit ...... atic review and meta-analysis.
@en
type
label
BRAF mutations in patients wit ...... atic review and meta-analysis.
@ast
BRAF mutations in patients wit ...... atic review and meta-analysis.
@en
prefLabel
BRAF mutations in patients wit ...... atic review and meta-analysis.
@ast
BRAF mutations in patients wit ...... atic review and meta-analysis.
@en
P2093
P2860
P31
P921
P1433
P1476
BRAF mutations in patients wit ...... atic review and meta-analysis.
@en
P2093
Da-Chuan Shi
Jun-Fu Huang
Li-Qun Zhang
Qing Huang
Wei-Ling Fu
Yun-Xia Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0101354
P407
P5008
P577
2014-06-30T00:00:00Z